Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β

Endocrinology

Volumn 140, Issue 2, 1999, Pages 800-804

  Sun, Jun ^a   Meyers, Marvin J ^a   Fink, Brian E ^a   Rajendran, Ramji ^b   Katzenellenbogen, John A ^a   Katzenellenbogen, Benita S ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR;

ARTICLE; BINDING AFFINITY; BONE DENSITY; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; ESTROGEN METABOLISM; HUMAN; HUMAN CELL; LIGAND BINDING; MEDIATOR RELEASE; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0004752110     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.2.6480     Document Type: Article

References (20)

1. 1. Katzenellenbogen BS, Korach KS 1997 Editorial: a new actor in the estrogen receptor drama-enter ERβ. Endocrinology 138:861-862
2. 2. Mosselmen S, Polman J, Dijkema R 1996 ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53
3. 3. Kuiper GJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
4. 4. Kuiper GJM, Carlsson B, Grandien J, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870
5. 5. Wrenn CK, Katzenellenbogen BS 1993 Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J Biol Chem 268:24089-24098
6. 6. Kraus WL, McInerney EM, Katzenellenbogen BS 1995 Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc Natl Acad Sci USA 92:12314-12318
7. 7. Norris JD, Fan D, Wagner BL, McDonnell DP 1996 Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol 10:1605-1616
8. 8. Hwang KJ, O'Neil JP, Katzenellenbogen JA 1992 5,6,11,12-tetrahydrochrysenes: synthesis of rigid stilbene systems designed to be fluorescent ligands for the estrogen receptor. J Org Chem 57:1262-1271
9. 9. Hwang KJ, Carlson KE, Anstead GM, Katzenellenbogen JA 1992 Donor-acceptor tetrahydrochrysenes, inherently fluorescent, high affinity ligands for the estrogen receptor: binding and fluorescence characteristics, and fluorometric assay for receptor. Biochemistry 31:11536-11545
10. 10. Montano MM, Müller V, Trobaugh A, Katzenellenbogen BS 1995 The carboxyl-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol Endocrinol 9:814-825
11. 11. McInerney EM, Katzenellenbogen BS 1996 Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J Biol Chem 271:24172-24178
12. 12. Carlson KE, Choi I, Gee A, Katzenellenbogen BS, Katzenellenbogen JA 1997 Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open-pocket conformation is required for ligand interaction. Biochemistry 36:14897-14905
13. 13. Bentley R 1995 From optical activity in quartz to chiral drugs: molecular handedness in biology and medicine. Perspect Biol Med 38:188-229
14. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
15. 15. McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS 1998 Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras. Endocrinology 139:4513-4522
16. 16. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V 1997 Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol Endocrinol 11:353-365
17. 17 Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S 1998 Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol Pharmacol 54:105-112
18. 18. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS 1996 Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10:119-131
19. 19. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
20. 20. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J-A, Carlquist M 1997 Molecular basis of agonism and antagonism in the estrogen receptor. Nature 389:753-758